DJIA 18,024.06 183.54 1.03%
NASDAQ 5,005.39 63.97 1.29%
S&P 500 2,108.29 22.78 1.09%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

106.89 5.02 (4.93%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $106.89 4.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.77
Previous Close $101.87
Daily Range $101.52 - $107.11
52-Week Range $47.42 - $132.99
Market Cap $9.0B
P/E Ratio -21.00
Dividend (Yield) $0.00 (0.0%)
Volume 786,430
Average Daily Volume 740,979
Current FY EPS -$2.90

Sector

Healthcare

Industry

Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary

Why Alnylam Pharmaceuticals, Inc. Shares Are Soaring Today

Alnylam Pharmaceuticals, Inc. has reported positive phase 2 results for patisiran.

The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Relea

The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Releases

3 Biotech Stocks Still Attractive After Monday's Sell-Off - Analyst Blog

Is Alnylam In 2020 Worth $9 Billion Now?

InsiderInsights.com Daily Round Up 4/23/15: GE, OMN, COCP, AGCO

The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases

Use Options For a Chance To Buy ALNY at a 32% Discount

Alnylam Strengthens Its Clinical Case Once Again

Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog

See More ALNY News...

ALNY's Top Competitors

ALNY $106.89 (4.93%)
Current stock: ALNY
AMGN $160.36 (1.55%)
Current stock: AMGN
GILD $105.01 (4.48%)
Current stock: GILD
BIIB $386.22 (3.29%)
Current stock: BIIB